{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:09:33Z","timestamp":1793084973412,"version":"4.5.0"},"reference-count":275,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":127,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101242","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T06:59:50Z","timestamp":1778309990000},"page":"101242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Precision breast oncology: molecular insights and transformative clinical strategies"],"prefix":"10.1016","volume":"47","author":[{"given":"Bindiya","family":"Chauhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyaul","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirza Salman","family":"Baig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajni","family":"Tanwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sophia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Intakhab","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3455-8443","authenticated-orcid":false,"given":"Md","family":"Faiyazuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ctarc.2026.101242_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101242_bib0002","first-page":"287","article-title":"Global burden of female breast cancer: new estimates in 2022, temporal trend and future projections up to 2050 based on the latest release from GLOBOCAN","volume":"5","author":"Zhang","year":"2025","journal-title":"J. Natl. Cancer Cent."},{"issue":"Suppl 10","key":"10.1016\/j.ctarc.2026.101242_bib0003","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1002\/cncr.32910","article-title":"Breast cancer treatment: a phased approach to implementation","volume":"126","author":"Mutebi","year":"2020","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101242_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12968\/hmed.2021.0459","article-title":"Breast cancer: presentation, investigation and management","volume":"83","author":"Katsura","year":"2022","journal-title":"Br. J. Hosp. Med."},{"key":"10.1016\/j.ctarc.2026.101242_bib0005","article-title":"Tissue engineering scaffolds loaded with a variety of plant extracts: novel model in breast cancer therapy","volume":"18","author":"Azhari Rad","year":"2024","journal-title":"Breast Cancer: Basic Clin. Res."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0006","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41392-024-01779-3","article-title":"Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance","volume":"9","author":"Wang","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101242_bib0007","first-page":"275","article-title":"Breast cancer progression and its theranostic management via folate-directed targeting of glycoprotein receptor","volume":"13","author":"Girigoswami","year":"2025","journal-title":"Med. Sci."},{"key":"10.1016\/j.ctarc.2026.101242_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106535","article-title":"Breast cancer: biology, biomarkers, and treatments","volume":"84","author":"Barzaman","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ctarc.2026.101242_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.pmbts.2017.07.002","article-title":"Breast cancer epidemiology, prevention, and screening","volume":"151","author":"Winters","year":"2017","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.ctarc.2026.101242_bib0010","series-title":"The Palgrave Encyclopedia of Disability","first-page":"1","article-title":"Breast cancer, subtypes, risk factors, and treatment","author":"Yousefnia","year":"2024"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101242_bib0011","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/14737140.2021.1840984","article-title":"Triple-negative breast cancer: promising prognostic biomarkers currently in development","volume":"21","author":"Sukumar","year":"2021","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0012","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/PAP.0000000000000232","article-title":"Molecular classification of breast cancer","volume":"27","author":"Tsang","year":"2020","journal-title":"Adv. Anat. Pathol."},{"issue":"10074","key":"10.1016\/j.ctarc.2026.101242_bib0013","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0140-6736(16)31891-8","article-title":"Breast cancer","volume":"389","author":"Harbeck","year":"2017","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101242_bib0014","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.annonc.2024.06.009","article-title":"Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers","volume":"35","author":"Arecco","year":"2024","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11033-025-11231-6","article-title":"Tumor microenvironment in breast cancer: cellular crosstalk, pathways, and therapeutic insights","volume":"53","author":"Sharma","year":"2025","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0016","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast cancer: pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"12","key":"10.1016\/j.ctarc.2026.101242_bib0017","doi-asserted-by":"crossref","first-page":"6806","DOI":"10.3390\/ijms23126806","article-title":"Breast cancer metastasis: mechanisms and therapeutic implications","volume":"23","author":"Park","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"21","key":"10.1016\/j.ctarc.2026.101242_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115625","article-title":"Organ-specificity of breast cancer metastasis","volume":"24","author":"Ibragimova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101242_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16101791","article-title":"Overall survival and prognostic factors in metastatic triple-negative breast cancer: a national cancer database analysis","volume":"16","author":"Kesireddy","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.ctarc.2026.101242_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.772305","article-title":"Novel pathways for targeting tumor angiogenesis in metastatic breast cancer","volume":"11","author":"Harry","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ctarc.2026.101242_bib0021","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2147\/OTT.S550104","article-title":"Precision nanomedicine for cancer: innovations, strategies, and translational challenges","volume":"18","author":"Wen","year":"2025","journal-title":"Onco Targets. Ther."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101242_bib0022","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3892\/mco.2024.2776","article-title":"Precision medicine in breast cancer (Review)","volume":"21","author":"Papalexis","year":"2024","journal-title":"Mol. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101242_bib0023","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s12247-025-09994-3","article-title":"Statistical formulation optimization of naproxen microsponges with Eudragit RS100 for sustained drug release","volume":"20","author":"Gupta","year":"2025","journal-title":"J. Pharm. Innov."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101242_bib0024","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nm.4309","article-title":"Gpr124 is essential for blood\u2013brain barrier integrity in central nervous system disease","volume":"23","author":"Chang","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.ctarc.2026.101242_bib0025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.addr.2019.05.004","article-title":"Strategies, design, and chemistry in siRNA delivery systems","volume":"144","author":"Dong","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101242_bib0026","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/nnano.2017.83","article-title":"Sparse coding with memristor networks","volume":"12","author":"Sheridan","year":"2017","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ctarc.2026.101242_bib0027","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.3389\/fonc.2021.610303","article-title":"The crosstalk between tumor cells and the immune microenvironment in breast cancer: implications for immunotherapy","volume":"11","author":"Salemme","year":"2021","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101242_bib0028","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nm.4508","article-title":"An immunosuppressive pathway for tumor progression","volume":"24","author":"Mar\u00e7ais","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ctarc.2026.101242_bib0029","article-title":"Research progress of HIF-1a on immunotherapy outcomes in immune vascular microenvironment","volume":"16","author":"Shi","year":"2025","journal-title":"Front. Immunol."},{"issue":"20","key":"10.1016\/j.ctarc.2026.101242_bib0030","doi-asserted-by":"crossref","first-page":"14017","DOI":"10.1039\/D4RA02639J","article-title":"Nanoscale strides: exploring innovative therapies for breast cancer treatment","volume":"14","author":"Mugundhan","year":"2024","journal-title":"RSC Adv."},{"issue":"12","key":"10.1016\/j.ctarc.2026.101242_bib0031","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s42452-023-05593-4","article-title":"Cancer nanomedicine: emergence, expansion, and expectations","volume":"5","author":"Kizhakkanoodan","year":"2023","journal-title":"SN Appl. Sci."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101242_bib0032","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29092073","article-title":"Therapeutic applications of nanomedicine: recent developments and future perspectives","volume":"29","author":"Rehan","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.ctarc.2026.101242_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.nxnano.2025.100336","article-title":"Innovations in targeted drug delivery: from nanotechnology to clinical applications","volume":"9","author":"Srivastava","year":"2026","journal-title":"Next Nanotechnol."},{"issue":"null","key":"10.1016\/j.ctarc.2026.101242_bib0034","article-title":"Nanotechnology-driven cancer therapies for precision oncology: advances and clinical outlook","volume":"21","author":"Gupta","year":"2026","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101242_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17020276","article-title":"Navigating the clinical landscape of liposomal therapeutics in cancer treatment","volume":"17","author":"Kozak","year":"2025","journal-title":"Pharmaceutics"},{"issue":"17","key":"10.1016\/j.ctarc.2026.101242_bib0036","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.3390\/nano12172948","article-title":"Lipid-based nanomaterials for drug delivery systems in breast cancer therapy","volume":"12","author":"Rethi","year":"2022","journal-title":"Nanomaterials"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101242_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09394","article-title":"Liposomes: structure, composition, types, and clinical applications","volume":"8","author":"Nsairat","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.ctarc.2026.101242_bib0038","series-title":"Liposomes in Drug Delivery","first-page":"19","article-title":"Chapter 2 - basic concepts of liposomes: components, structures, properties and classification","author":"Musumeci","year":"2024"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101242_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09394","article-title":"Liposomes: structure, composition, types, and clinical applications","volume":"8","author":"Nsairat","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.ctarc.2026.101242_bib0040","article-title":"Sustained and targeted delivery of hydrophilic drug compounds: A review of existing and novel technologies from bench to bedside","volume":"78","author":"Hawthorne","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"16","key":"10.1016\/j.ctarc.2026.101242_bib0041","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.3390\/molecules25163731","article-title":"Polymeric nanoparticles: production, characterization, toxicology and ecotoxicology","volume":"25","author":"Zieli\u0144ska","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ctarc.2026.101242_bib0042","doi-asserted-by":"crossref","DOI":"10.3389\/fmats.2021.798440","article-title":"Quantum dots: an emerging approach for cancer therapy","volume":"8","author":"Devi","year":"2022","journal-title":"Front. Mater."},{"issue":"18","key":"10.1016\/j.ctarc.2026.101242_bib0043","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.3390\/nano13182566","article-title":"Recent breakthroughs in using quantum dots for cancer imaging and drug delivery purposes","volume":"13","author":"Hamidu","year":"2023","journal-title":"Nanomaterials"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101242_bib0044","doi-asserted-by":"crossref","DOI":"10.1002\/ppsc.201800302","article-title":"State-of-the-art and trends in synthesis, properties, and application of quantum dots-based nanomaterials","volume":"36","author":"Alizadeh-Ghodsi","year":"2019","journal-title":"Part. Part Syst. Charact."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101242_bib0045","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.1021\/acsanm.0c01386","article-title":"Quantum dots and their applications: what lies ahead?","volume":"3","author":"Cotta","year":"2020","journal-title":"ACS Appl. Nano Mater."},{"issue":"18","key":"10.1016\/j.ctarc.2026.101242_bib0046","doi-asserted-by":"crossref","DOI":"10.3390\/nano13182566","article-title":"Recent breakthroughs in using quantum dots for cancer imaging and drug delivery purposes","volume":"13","author":"Hamidu","year":"2023","journal-title":"Nanomaterials"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101242_bib0047","article-title":"Exploring research on the drug loading capacity of quantum dots","volume":"16","author":"Noel","year":"2024","journal-title":"Cureus"},{"issue":"12","key":"10.1016\/j.ctarc.2026.101242_bib0048","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.3390\/cancers12123727","article-title":"NIR imaging of the integrin-rich head and neck squamous cell carcinoma using ternary copper indium selenide\/zinc sulfide-based quantum dots","volume":"12","author":"Yakavets","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0049","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1080\/10717544.2022.2039804","article-title":"Metal nanoparticles as a promising technology in targeted cancer treatment","volume":"29","author":"Xu","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ctarc.2026.101242_bib0050","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jcis.2020.02.051","article-title":"Mesoporous platinum nanoparticle-based nanoplatforms for combined chemo-photothermal breast cancer therapy","volume":"570","author":"Fu","year":"2020","journal-title":"J. Colloid. Interface Sci."},{"issue":"21","key":"10.1016\/j.ctarc.2026.101242_bib0051","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.3390\/molecules26216532","article-title":"Metal nanoparticles for photodynamic therapy: a potential treatment for breast cancer","volume":"26","author":"Shang","year":"2021","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.ctarc.2026.101242_bib0052","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101242_bib0053","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1021\/acsmaterialsau.3c00032","article-title":"Lipid-based nanoparticles for drug\/gene delivery: an overview of the production techniques and difficulties encountered in their industrial development","volume":"3","author":"Mehta","year":"2023","journal-title":"ACS Mater. Au"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101242_bib0054","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.3390\/cancers15082256","article-title":"A recent review on cancer nanomedicine","volume":"15","author":"Giri","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ctarc.2026.101242_bib0055","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pdpdt.2019.03.016","article-title":"Role of various nanoparticles in photodynamic therapy and detection methods of singlet oxygen","volume":"26","author":"Krajczewski","year":"2019","journal-title":"Photodiagnosis. Photodyn. Ther."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0056","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12951-023-01973-5","article-title":"Extracellular vesicles: a rising star for therapeutics and drug delivery","volume":"21","author":"Du","year":"2023","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.ctarc.2026.101242_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2024.101715","article-title":"Photosensitizers in photodynamic therapy: an advancement in cancer treatment","volume":"10","author":"Oluwajembola","year":"2024","journal-title":"Results. Chem."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101242_bib0058","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1039\/D0QM00922A","article-title":"Photodynamic therapy: photosensitizers and nanostructures","volume":"5","author":"Escudero","year":"2021","journal-title":"Mater. Chem. Front."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101242_bib0059","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1111\/php.13470","article-title":"Photosensitization reactions of biomolecules: definition, targets and mechanisms","volume":"97","author":"Baptista","year":"2021","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.ctarc.2026.101242_bib0060","article-title":"Photodynamic Therapy (PDT) in drug delivery: nano-innovations enhancing treatment outcomes","volume":"14","author":"Al-Jamal","year":"2025","journal-title":"Health Sci. Rev."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0061","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41420-024-02121-0","article-title":"Nanomedicine-induced programmed cell death in cancer therapy: mechanisms and perspectives","volume":"10","author":"Luobin","year":"2024","journal-title":"Cell Death. Discov."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101242_bib0062","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s13205-023-03901-8","article-title":"Advances in functional lipid nanoparticles: from drug delivery platforms to clinical applications","volume":"14","author":"Dhayalan","year":"2024","journal-title":"3 Biotech"},{"key":"10.1016\/j.ctarc.2026.101242_bib0063","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jconrel.2023.01.018","article-title":"Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases","volume":"354","author":"Onugwu","year":"2023","journal-title":"J. Control Release"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101242_bib0064","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/pharmaceutics12020102","article-title":"Opportunities and challenges in the delivery of mRNA-based vaccines","volume":"12","author":"Wadhwa","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ctarc.2026.101242_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.nxnano.2025.100172","article-title":"Quantum dot nanotechnology: advancing target drug delivery in oncology","volume":"7","author":"Hanmante","year":"2025","journal-title":"Next Nanotechnol."},{"key":"10.1016\/j.ctarc.2026.101242_bib0066","doi-asserted-by":"crossref","first-page":"13039","DOI":"10.2147\/IJN.S554821","article-title":"Bridging the gap: the role of advanced formulation strategies in the clinical translation of nanoparticle-based drug delivery systems","volume":"20","author":"Herdiana","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ctarc.2026.101242_bib0067","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2025.214636","article-title":"Enhanced permeability and retention (EPR) effect: advances in nanomedicine for improved tumor targeting","volume":"181","author":"Khan","year":"2026","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.ctarc.2026.101242_bib0068","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.addr.2018.07.007","article-title":"Tumor targeting via EPR: strategies to enhance patient responses","volume":"130","author":"Golombek","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101242_bib0069","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.apsb.2025.03.040","article-title":"Precise nanoscale fabrication technologies, the \u201clast mile\u201d of medicinal development","volume":"15","author":"Bi","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ctarc.2026.101242_bib0070","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2026.1735885","article-title":"Regulatory framework for polymer-based nanotherapeutics in clinical translation","volume":"14","author":"Stucchi","year":"2026","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101242_bib0071","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17080987","article-title":"Nanomedicine: the effective role of nanomaterials in healthcare from diagnosis to therapy","volume":"17","author":"Kazi","year":"2025","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0072","article-title":"Thirty years from FDA approval of pegylated liposomal doxorubicin (Doxil\/Caelyx): an updated analysis and future perspective","volume":"4","author":"Gabizon","year":"2025","journal-title":"BMJ Oncol."},{"issue":"20","key":"10.1016\/j.ctarc.2026.101242_bib0073","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.3390\/cancers15205036","article-title":"Prospective, multicenter Phase II trial of non-pegylated liposomal doxorubicin combined with Ifosfamide in first-line treatment of advanced\/metastatic soft tissue sarcomas","volume":"15","author":"Buonadonna","year":"2023","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101242_bib0074","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s13346-024-01654-2","article-title":"Synergistic effects of thermosensitive liposomal doxorubicin, mild hyperthermia, and radiotherapy in breast cancer management: an orthotopic mouse model study","volume":"15","author":"Wang","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ctarc.2026.101242_bib0075","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejpb.2023.10.022","article-title":"Challenges of nanoparticle albumin bound (nab\u2122) technology: comparative study of Abraxane\u00ae with a newly developed albumin-stabilized itraconazole nanosuspension","volume":"193","author":"Adick","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ctarc.2026.101242_bib0076","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120946","article-title":"Continuous processing of paclitaxel polymeric micelles","volume":"607","author":"Gupta","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ctarc.2026.101242_bib0077","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125985","article-title":"Design of paclitaxel-loaded PLGA nanoparticles assisted by compatibility modeling","volume":"682","author":"Zem\u00e1nkov\u00e1","year":"2025","journal-title":"Int. J. Pharm."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101242_bib0078","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1080\/17435889.2025.2501526","article-title":"Anticancer efficacy of dual-loaded SLNs with Doxorubicin (DOX) and pterostilbene (PTS): formulation, characterization, and evaluation for breast cancer","volume":"20","author":"Marwah","year":"2025","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0079","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s13346-025-01865-1","article-title":"Radiolabelling and bioequivalence of modified Tamoxifen solid lipid nanoparticles as a targeted chemotherapeutic drug","volume":"16","author":"Abdel-Rashid","year":"2026","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ctarc.2026.101242_bib0080","article-title":"Gold nanoparticles in transferrin-targeted dual-drug delivery in vitro","volume":"90","author":"David","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0081","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15010236","article-title":"Superparamagnetic iron oxide nanoparticles (SPION): from fundamentals to State-of-the-art innovative applications for cancer therapy","volume":"15","author":"Vangijzegem","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ctarc.2026.101242_bib0082","series-title":"Biomedical Translational Research: Technologies for Improving Healthcare","first-page":"371","article-title":"Fluorescent quantum dots (QDs): a theranostic tool for breast cancer management","author":"Singh","year":"2022"},{"issue":"12","key":"10.1016\/j.ctarc.2026.101242_bib0083","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101242_bib0084","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11080808","article-title":"Breast cancer treatments: updates and new challenges","volume":"11","author":"Burguin","year":"2021","journal-title":"J. Pers. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0085","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/php.12997","article-title":"Cytotoxic and photocytotoxic effects of cercosporin on human tumor cell lines","volume":"95","author":"Mastrangelopoulou","year":"2019","journal-title":"Photochem. Photobiol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101242_bib0086","doi-asserted-by":"crossref","first-page":"e2065","DOI":"10.1002\/hsr2.2065","article-title":"Current approaches in smart nano-inspired drug delivery: a narrative review","volume":"7","author":"Boppana","year":"2024","journal-title":"Health Sci. Rep."},{"key":"10.1016\/j.ctarc.2026.101242_bib0087","doi-asserted-by":"crossref","DOI":"10.1016\/j.nanoso.2024.101403","article-title":"Nanomedicine and drug delivery: a comprehensive review of applications and challenges","volume":"40","author":"Singh","year":"2024","journal-title":"Nano-Struct. Nano-Objects"},{"key":"10.1016\/j.ctarc.2026.101242_bib0088","unstructured":"Biswas P, Saha A, Sridhar B, Patel A, Desai BMA. Quantum dots as functional nanosystems for enhanced biomedical applications. arXiv preprint arXiv:250515705. 2025."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0089","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s44301-026-00026-8","article-title":"Selecting nanocarrier platforms for drug delivery: a criteria-based, translational review integrating CQA\/CMC and immune interactions","volume":"2","author":"Hocao\u011flu","year":"2026","journal-title":"Health Nanotechnol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101242_bib0090","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.cpt.2024.10.001","article-title":"An overview of randomized phase III clinical trials of cancer nanomedicines","volume":"3","author":"Melo","year":"2025","journal-title":"Cancer Pathog. Ther."},{"key":"10.1016\/j.ctarc.2026.101242_bib0091","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/3687700","article-title":"Paclitaxel: application in modern oncology and nanomedicine-based cancer therapy","volume":"2021","author":"Sharifi-Rad","year":"2021","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.ctarc.2026.101242_bib0092","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70733","article-title":"Targeted therapies for each subtype of breast cancer","volume":"7","author":"Liu","year":"2026","journal-title":"MedComm"},{"key":"10.1016\/j.ctarc.2026.101242_bib0093","doi-asserted-by":"crossref","DOI":"10.1016\/j.aspetd.2025.100012","article-title":"Integrative strategies in breast cancer therapy: conventional approaches, emerging advances, and future challenges","volume":"1","author":"Eapen","year":"2025","journal-title":"ASPET Discov."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101242_bib0094","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12247-025-10135-z","article-title":"Optimization and evaluation of itopride hydrochloride-loaded eudragit S100\/ethylcellulose gastroretentive electrospun nanofibers for the treatment of gastroesophageal reflux disease","volume":"20","author":"Dass","year":"2025","journal-title":"J. Pharm. Innov."},{"key":"10.1016\/j.ctarc.2026.101242_bib0095","article-title":"Fluorescent quantum dots: an insight on synthesis and potential biological application as drug carrier in cancer","volume":"26","author":"Tandale","year":"2021","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.ctarc.2026.101242_bib0096","doi-asserted-by":"crossref","DOI":"10.1016\/j.adcanc.2026.100183","article-title":"HER2-targeted therapy resistance in breast cancer: molecular mechanisms, therapeutic evolution, and precision oncology approaches","volume":"17","author":"Javeed","year":"2026","journal-title":"Adv. Cancer Biol. - Metastasis"},{"key":"10.1016\/j.ctarc.2026.101242_bib0097","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.2147\/IJN.S140325","article-title":"Drug delivery approaches for breast cancer","volume":"12","author":"Singh","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101242_bib0098","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076834","article-title":"A basic review on estrogen receptor signaling pathways in breast cancer","volume":"24","author":"Clusan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ctarc.2026.101242_bib0099","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.12.012","article-title":"Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment","volume":"186","author":"Patel","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ctarc.2026.101242_bib0100","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2147\/DDDT.S336643","article-title":"The role of progesterone receptors in breast cancer","volume":"16","author":"Li","year":"2022","journal-title":"Drug Dev. Ther."},{"key":"10.1016\/j.ctarc.2026.101242_bib0101","article-title":"Prognostic relevance of estrogen receptor status in circulating tumor cells in breast cancer patients treated with endocrine therapy","volume":"12","author":"Zhou","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ctarc.2026.101242_bib0102","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/852748","article-title":"Human epidermal growth factor receptor 2 (HER2) in cancers: overexpression and therapeutic implications","volume":"2014","author":"Iqbal","year":"2014","journal-title":"Mol. Biol. Int."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101242_bib0103","doi-asserted-by":"crossref","DOI":"10.3390\/genes15070903","article-title":"A comprehensive review of HER2 in cancer biology and therapeutics","volume":"15","author":"Cheng","year":"2024","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0104","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41523-023-00533-2","article-title":"Estrogen\/HER2 receptor crosstalk in breast cancer: combination therapies to improve outcomes for patients with hormone receptor-positive\/HER2-positive breast cancer","volume":"9","author":"Pegram","year":"2023","journal-title":"NPJ Breast. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/curroncol33010041","article-title":"The role of androgen receptor and antiandrogen therapy in breast cancer: a scoping review","volume":"33","author":"Ghidini","year":"2026","journal-title":"Curr. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0106","doi-asserted-by":"crossref","DOI":"10.1002\/cbf.70166","article-title":"Targeting estrogen pathways in breast cancer: a review of current therapies and emerging strategies","volume":"44","author":"Dabhi","year":"2026","journal-title":"Cell Biochem. Funct."},{"issue":"21","key":"10.1016\/j.ctarc.2026.101242_bib0107","doi-asserted-by":"crossref","first-page":"5206","DOI":"10.3390\/cancers14215206","article-title":"Molecular mechanisms of anti-estrogen therapy resistance and novel targeted therapies","volume":"14","author":"Ozyurt","year":"2022","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101242_bib0108","doi-asserted-by":"crossref","first-page":"6834","DOI":"10.3390\/ijms24076834","article-title":"A basic review on estrogen receptor signaling pathways in breast cancer","volume":"24","author":"Clusan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101242_bib0109","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/annonc\/mdy192","article-title":"4th ESO-ESMO International Consensus Guidelines for advanced breast cancer (ABC 4)\u2020","volume":"29","author":"Cardoso","year":"2018","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101242_bib0110","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1158\/1078-0432.CCR-25-1982","article-title":"Advances in targeting HER2 across cancer subtypes: a pan-tumor approach","volume":"32","author":"Adesoye","year":"2026","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101242_bib0111","first-page":"1045","article-title":"The trastuzumab era: current and upcoming targeted HER2+ breast cancer therapies","volume":"10","author":"Kreutzfeldt","year":"2020","journal-title":"Am. J. Cancer Res."},{"issue":"14","key":"10.1016\/j.ctarc.2026.101242_bib0112","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13143540","article-title":"Trastuzumab mechanism of action; 20 years of research to unravel a dilemma","volume":"13","author":"Maadi","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101242_bib0113","first-page":"186","article-title":"Role of the androgen receptor in triple-negative breast cancer","volume":"14","author":"Rampurwala","year":"2016","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"10.1016\/j.ctarc.2026.101242_bib0114","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.977331","article-title":"Androgen receptor in breast cancer: the \"5W\" questions","volume":"13","author":"Ravaioli","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101242_bib0115","doi-asserted-by":"crossref","first-page":"e2065","DOI":"10.1002\/hsr2.2065","article-title":"Current approaches in smart nano-inspired drug delivery: a narrative review","volume":"7","author":"Boppana","year":"2024","journal-title":"Health Sci. Rep."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101242_bib0116","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2174\/0115748928267931231120065335","article-title":"Targeting the key signaling pathways in breast cancer: from molecular mechanism to therapeutic interventions","volume":"20","author":"Singh","year":"2025","journal-title":"Recent. Pat. AntiCancer Drug Discov."},{"key":"10.1016\/j.ctarc.2026.101242_bib0117","article-title":"Recent insights into breast cancer: molecular pathways, epigenetic regulation, and emerging targeted therapies","volume":"19","author":"Maqsood","year":"2025","journal-title":"Breast Cancer: Basic Clin. Res."},{"key":"10.1016\/j.ctarc.2026.101242_bib0118","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0119","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41421-023-00523-5","article-title":"Structure and dynamics of the EGFR\/HER2 heterodimer","volume":"9","author":"Bai","year":"2023","journal-title":"Cell Discov."},{"key":"10.1016\/j.ctarc.2026.101242_bib0120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.21037\/tbcr-23-44","article-title":"Androgen receptor in breast cancer and its clinical implication","volume":"4","author":"Hackbart","year":"2023","journal-title":"Transl. Breast Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101242_bib0121","doi-asserted-by":"crossref","unstructured":"Zhang Z, Bai X, Sun P, Wang X, Long C, Liao S, et al. Structure and dynamics of the EGFR\/HER2 heterodimer. 2023.","DOI":"10.21203\/rs.3.rs-2049071\/v1"},{"key":"10.1016\/j.ctarc.2026.101242_bib0122","series-title":"Nuclear Receptors: The Art and Science of Modulator Design and Discovery","author":"Badr","year":"2021"},{"key":"10.1016\/j.ctarc.2026.101242_bib0123","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.breast.2019.02.009","article-title":"Comparison of 4th ESO\u2013ESMO international consensus guidelines for advance breast cancer and Chinese anti-cancer association committee of Breast Cancer Society guideline","volume":"45","author":"Hu","year":"2019","journal-title":"Breast"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101242_bib0124","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1039\/C8NR07769J","article-title":"Applications of nanoparticles in biomedical imaging","volume":"11","author":"Han","year":"2019","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0125","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41392-024-01889-y","article-title":"Current advance of nanotechnology in diagnosis and treatment for malignant tumors","volume":"9","author":"Wang","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101242_bib0126","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3892\/br.2021.1418","article-title":"Nanotechnology and its use in imaging and drug delivery (Review)","volume":"14","author":"Sim","year":"2021","journal-title":"Biomed. Rep."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0127","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s13659-023-00415-x","article-title":"A recent update on development, synthesis methods, properties and application of natural products derived carbon dots","volume":"13","author":"Sahana","year":"2023","journal-title":"Nat. Prod. Bioprospecting"},{"key":"10.1016\/j.ctarc.2026.101242_bib0128","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1016\/j.biomaterials.2010.12.053","article-title":"Patterns of cancer invasion revealed by QDs-based quantitative multiplexed imaging of tumor microenvironment","volume":"32","author":"Peng","year":"2011","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.ctarc.2026.101242_bib0129","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1021\/acs.molpharmaceut.7b00532","article-title":"In vivo pulmonary delivery and magnetic-targeting of dry powder nano-in-microparticles","volume":"14","author":"Price","year":"2017","journal-title":"Mol. Pharm."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101242_bib0130","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2217\/nnm-2017-0336","article-title":"Magnetic iron oxide nanoparticles as drug carriers: clinical relevance","volume":"13","author":"El-Boubbou","year":"2018","journal-title":"Nanomedicine"},{"issue":"17","key":"10.1016\/j.ctarc.2026.101242_bib0131","doi-asserted-by":"crossref","first-page":"9315","DOI":"10.3390\/ijms25179315","article-title":"Gold nanoparticles for retinal molecular optical imaging","volume":"25","author":"Park","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"10.1016\/j.ctarc.2026.101242_bib0132","doi-asserted-by":"crossref","first-page":"15605","DOI":"10.1021\/acsnano.3c02370","article-title":"Engineering Au44 nanoclusters for NIR-II luminescence imaging-guided photoactivatable cancer immunotherapy","volume":"17","author":"Yang","year":"2023","journal-title":"ACS Nano"},{"issue":"41","key":"10.1016\/j.ctarc.2026.101242_bib0133","doi-asserted-by":"crossref","first-page":"10003","DOI":"10.1039\/D3TB01736B","article-title":"Biotin-decorated hollow gold nanoshells for dual-modal imaging-guided NIR-II photothermal and radiosensitizing therapy toward breast cancer","volume":"11","author":"Chen","year":"2023","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ctarc.2026.101242_bib0134","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-06450-4","article-title":"Strong coupling and induced transparency at room temperature with single quantum dots and gap plasmons","volume":"9","author":"Leng","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0135","doi-asserted-by":"crossref","first-page":"80","DOI":"10.7150\/ntno.18216","article-title":"Gold nanoparticle based platforms for circulating cancer marker detection","volume":"1","author":"Huang","year":"2017","journal-title":"Nanotheranostics"},{"key":"10.1016\/j.ctarc.2026.101242_bib0136","series-title":"Gold Nanoparticles to Tackle Drug Resistance in Cancer","author":"Pedrosa","year":"2019"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101242_bib0137","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1021\/acssensors.7b00382","article-title":"Single-molecule plasmon sensing: current status and future prospects","volume":"2","author":"Taylor","year":"2017","journal-title":"ACS Sens."},{"key":"10.1016\/j.ctarc.2026.101242_bib0138","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.nantod.2018.12.006","article-title":"Gold nanoparticles in biological optical imaging","volume":"24","author":"Wu","year":"2019","journal-title":"Nano Today"},{"issue":"22","key":"10.1016\/j.ctarc.2026.101242_bib0139","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.3390\/nano14221854","article-title":"Gold nanoparticles in nanomedicine: unique properties and therapeutic potential","volume":"14","author":"Eker","year":"2024","journal-title":"Nanomaterials"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0140","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s40820-023-01266-4","article-title":"Biological interaction and imaging of ultrasmall gold nanoparticles","volume":"16","author":"Sang","year":"2023","journal-title":"Nano-Micro Lett."},{"key":"10.1016\/j.ctarc.2026.101242_bib0141","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5164970","article-title":"Modern diagnostic imaging technique applications and risk factors in the medical field: a review","volume":"2022","author":"Hussain","year":"2022","journal-title":"Biomed. Res. Int."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101242_bib0142","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1021\/acs.chemrev.8b00363","article-title":"Chemistry of MRI contrast agents: current challenges and new frontiers","volume":"119","author":"Wahsner","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ctarc.2026.101242_bib0143","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejro.2023.100503","article-title":"Gadolinium contrast agents- challenges and opportunities of a multidisciplinary approach: literature review","volume":"11","author":"Iyad","year":"2023","journal-title":"Eur. J. Radiol. Open."},{"issue":"1 S 1","key":"10.1016\/j.ctarc.2026.101242_bib0144","first-page":"S61","article-title":"Contrast media research symposium 2022","volume":"24","author":"Akif","year":"2022","journal-title":"Mol. Imag. Biol."},{"key":"10.1016\/j.ctarc.2026.101242_bib0145","series-title":"Surface-modified Nanobiomaterials for Electrochemical and Biomedicine Applications","first-page":"49","article-title":"Magnetic nanoparticles as MRI contrast agents","author":"Avasthi","year":"2020"},{"issue":"21","key":"10.1016\/j.ctarc.2026.101242_bib0146","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13215285","article-title":"Magnetic particle imaging: an emerging modality with prospects in diagnosis, targeting and therapy of cancer","volume":"13","author":"Tay","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ctarc.2026.101242_bib0147","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.3390\/ma13173795","article-title":"Mesoporous silica nanoparticles in bioimaging","volume":"13","author":"Yuan","year":"2020","journal-title":"Materials"},{"key":"10.1016\/j.ctarc.2026.101242_bib0148","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1845637","article-title":"Nanoparticle-based paramagnetic contrast agents for magnetic resonance imaging","volume":"2019","author":"Pellico","year":"2019","journal-title":"Contrast. Media Mol. Imaging"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0149","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s13404-025-00357-x","article-title":"An updated review on the potential of gold nanoparticles for cancer treatment and detection","volume":"58","author":"Choudhary","year":"2025","journal-title":"Gold. Bull."},{"key":"10.1016\/j.ctarc.2026.101242_bib0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.128599","article-title":"Metallic nanoparticles as X-ray computed tomography (CT) contrast agents: a review","volume":"1219","author":"Aslan","year":"2020","journal-title":"J. Mol. Struct."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101242_bib0151","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/ird3.70035","article-title":"Ultrasmall superparamagnetic iron oxide nanoparticles as positive contrast agents in low-field magnetic resonance imaging","volume":"3","author":"Ngwu-Hyacinth","year":"2025","journal-title":"Iradiology"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101242_bib0152","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3390\/jnt4020007","article-title":"Consolidation of gold and gadolinium nanoparticles: an extra step towards improving cancer imaging and therapy","volume":"4","author":"Kouri","year":"2023","journal-title":"J. Nanotheranostics"},{"key":"10.1016\/j.ctarc.2026.101242_bib0153","article-title":"Gold nanomaterials for imaging-guided near-infrared in vivo cancer therapy","volume":"7 - 2019","author":"Tian","year":"2019","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101242_bib0154","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.7150\/thno.84253","article-title":"Photoacoustic imaging for investigating tumor hypoxia: a strategic assessment","volume":"13","author":"Nasri","year":"2023","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0155","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1038\/s41467-018-06271-5","article-title":"Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancer","volume":"9","author":"Chen","year":"2018","journal-title":"Nat. Commun."},{"issue":"18","key":"10.1016\/j.ctarc.2026.101242_bib0156","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1080\/14796694.2025.2520161","article-title":"Multimodal imaging in cancer detection: the role of SPIONs and USPIONs as contrast agents for MRI, SPECT, and PET","volume":"21","author":"Shaghaghi","year":"2025","journal-title":"Future Oncol."},{"key":"10.1016\/j.ctarc.2026.101242_bib0157","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpsurg.2026.101990","article-title":"Evaluation of preoperative lymphatic drainage imaging using indocyanine green for precise sentinel lymph node biopsy in breast cancer patients","author":"Li","year":"2026","journal-title":"Curr. Probl. Surg."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101242_bib0158","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1007\/s00542-025-05922-0","article-title":"Nanomaterials for biosensing: bridging mechanical engineering and molecular biology for early disease detection","volume":"31","author":"Wang","year":"2025","journal-title":"Microsyst. Technol."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101242_bib0159","article-title":"Guidance on how to develop complex interventions to improve health and healthcare","volume":"9","author":"O'Cathain","year":"2019","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101242_bib0160","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1039\/C7NR07398D","article-title":"A SERRS\/MRI multimodal contrast agent based on naked Au nanoparticles functionalized with a Gd(iii) loaded PEG polymer for tumor imaging and localized hyperthermia","volume":"10","author":"Litti","year":"2018","journal-title":"Nanoscale"},{"key":"10.1016\/j.ctarc.2026.101242_bib0161","series-title":"Methods in Enzymology","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/bs.mie.2019.06.022","article-title":"Chapter ten - systematic and site-specific analysis of N-glycoproteins on the cell surface by integrating bioorthogonal chemistry and MS-based proteomics","volume":"626","author":"Sun","year":"2019"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101242_bib0162","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.cell.2024.02.041","article-title":"Cancer biomarkers: emerging trends and clinical implications for personalized treatment","volume":"187","author":"Passaro","year":"2024","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101242_bib0163","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s12032-025-02817-y","article-title":"Precision oncology: transforming cancer care through personalized medicine","volume":"42","author":"Rituraj","year":"2025","journal-title":"Med. Oncol."},{"key":"10.1016\/j.ctarc.2026.101242_bib0164","article-title":"Protein biomarkers for diagnosis of breast cancer","volume":"25","author":"Iweala","year":"2024","journal-title":"Sci. Afr."},{"issue":"Suppl 1","key":"10.1016\/j.ctarc.2026.101242_bib0165","article-title":"Value, challenges and practical considerations when designing, conducting and analysing a longitudinal qualitative study in family medicine","volume":"9","author":"Wanat","year":"2021","journal-title":"Fam. Med. Community Health"},{"issue":"15","key":"10.1016\/j.ctarc.2026.101242_bib0166","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s41388-024-02973-x","article-title":"Cancer-associated fibroblasts rewire the estrogen receptor response in luminal breast cancer, enabling estrogen independence","volume":"43","author":"Reid","year":"2024","journal-title":"Oncogene"},{"issue":"20","key":"10.1016\/j.ctarc.2026.101242_bib0167","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.2018.77.8738","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists Clinical practice guideline focused update","volume":"36","author":"Wolff","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"13","key":"10.1016\/j.ctarc.2026.101242_bib0168","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1158\/1078-0432.CCR-22-0283","article-title":"Molecular pathways and mechanisms of HER2 in cancer therapy","volume":"29","author":"Raghav","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"17","key":"10.1016\/j.ctarc.2026.101242_bib0169","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13174455","article-title":"Ki-67 as a prognostic biomarker in invasive breast cancer","volume":"13","author":"Davey","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ctarc.2026.101242_bib0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2025.103847","article-title":"BRCA1 and BRCA2 in DNA damage and replication stress response: insights into their functions, mechanisms, and implications for cancer treatment","volume":"150","author":"Xu","year":"2025","journal-title":"DNA Repair"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0171","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188556","article-title":"Tumor suppressor p53: biology, signaling pathways, and therapeutic targeting","volume":"1876","author":"Hern\u00e1ndez Borrero","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101242_bib0172","article-title":"Oncogenic activation of PIK3CA in cancers: emerging targeted therapies in precision oncology","volume":"12","author":"Wang","year":"2025","journal-title":"Genes Dis."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101242_bib0173","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.gendis.2022.12.015","article-title":"Synthetic lethal approaches to target cancers with loss of PTEN function","volume":"10","author":"Ertay","year":"2023","journal-title":"Genes Dis."},{"key":"10.1016\/j.ctarc.2026.101242_bib0174","doi-asserted-by":"crossref","DOI":"10.1016\/j.seminoncol.2026.152466","article-title":"Advances in the management of metastatic lobular breast cancer: current evidence and emerging treatments","author":"Mart\u00edn-Quesada","year":"2026","journal-title":"Semin. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0175","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1038\/s41598-025-87403-y","article-title":"Relationship between androgen receptor and androgen receptor-related protein expression in breast cancers focusing on morphologically identified carcinoma with apocrine differentiation","volume":"15","author":"Nishida","year":"2025","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101242_bib0176","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1158\/2767-9764.CRC-24-0255","article-title":"Targeting the epidermal growth factor receptor pathway in chemotherapy-resistant triple-negative breast cancer: a phase II study","volume":"4","author":"Yam","year":"2024","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.ctarc.2026.101242_bib0177","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123087","article-title":"HER3: updates and current biology function, targeted therapy and pathologic detecting methods","volume":"357","author":"Gao","year":"2024","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0178","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","article-title":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer","volume":"8","author":"Liu","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.ctarc.2026.101242_bib0179","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1406951","article-title":"Fibroblast growth factor receptor signaling in estrogen receptor-positive breast cancer: mechanisms and role in endocrine resistance","volume":"14","author":"Marin","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ctarc.2026.101242_bib0180","article-title":"The utility of serum tumor markers CEA and CA 15\u20133 for breast cancer prognosis and their association with clinicopathological parameters","volume":"28","author":"Uygur","year":"2021","journal-title":"Cancer Treat. Res. Commun."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0181","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41698-025-01016-2","article-title":"Mucin-1: a promising pan-cancer therapeutic target","volume":"9","author":"Grewal","year":"2025","journal-title":"NPJ. Precis. Oncol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101242_bib0182","doi-asserted-by":"crossref","first-page":"999","DOI":"10.4240\/wjgs.v16.i4.999","article-title":"Carcinoembryonic antigen in the diagnosis, treatment, and follow-up of focal liver lesions","volume":"16","author":"Dilek","year":"2024","journal-title":"World J. Gastrointest. Surg."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0183","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41392-021-00817-8","article-title":"Circulating tumor cells: biology and clinical significance","volume":"6","author":"Lin","year":"2021","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0184","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41698-025-00876-y","article-title":"Circulating tumor DNA to monitor treatment response in solid tumors and advance precision oncology","volume":"9","author":"Bartolomucci","year":"2025","journal-title":"NPJ Precis. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0185","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-36321-3","article-title":"Plasma miR-21, miR-155, miR-10b, and let-7a as the potential biomarkers for the monitoring of breast cancer patients","volume":"8","author":"Khalighfard","year":"2018","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101242_bib0186","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ncrna.2024.01.015","article-title":"Long noncoding RNA MALAT-1: a versatile regulator in cancer progression, metastasis, immunity, and therapeutic resistance","volume":"9","author":"Xu","year":"2024","journal-title":"Non-coding RNA Res."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0187","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12943-022-01525-9","article-title":"Liquid biopsy: exosomal microRNAs as novel diagnostic and prognostic biomarkers in cancer","volume":"21","author":"Preethi","year":"2022","journal-title":"Mol. Cancer"},{"issue":"22","key":"10.1016\/j.ctarc.2026.101242_bib0188","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1056\/NEJMoa1809615","article-title":"Atezolizumab and Nab-paclitaxel in advanced triple-negative breast cancer","volume":"379","author":"Schmid","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ctarc.2026.101242_bib0189","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.155864","article-title":"Exploring immune checkpoint inhibitors: focus on PD-1\/PD-L1 axis and beyond","volume":"269","author":"Aden","year":"2025","journal-title":"Pathol. - Res. Pract."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101242_bib0190","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.clinbiochem.2004.05.013","article-title":"The urokinase plasminogen activator system: a rich source of tumor markers for the individualised management of patients with cancer","volume":"37","author":"Duffy","year":"2004","journal-title":"Clin. Biochem."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101242_bib0191","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/his.14863","article-title":"Evaluation oncotype DX(\u00ae) 21-gene recurrence score and clinicopathological parameters: a single institutional experience","volume":"82","author":"Lashen","year":"2023","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101242_bib0192","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2217\/fon-2018-0221","article-title":"Mammaprint\u2122: a comprehensive review","volume":"15","author":"Brand\u00e3o","year":"2019","journal-title":"Future Oncol."},{"key":"10.1016\/j.ctarc.2026.101242_bib0193","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.jmrt.2021.03.048","article-title":"Nano biosensors: properties, applications and electrochemical techniques","volume":"12","author":"Huang","year":"2021","journal-title":"J. Mater. Res. Technol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101242_bib0194","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/14787210.2022.2009343","article-title":"Ethical challenges of prospective clinical trials during the COVID-19 pandemic","volume":"20","author":"McCarthy","year":"2022","journal-title":"Expert. Rev. Anti. Infect. Ther."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101242_bib0195","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.3390\/pharmaceutics15071932","article-title":"Functionalized metal nanoparticles in cancer therapy","volume":"15","author":"Villalobos Guti\u00e9rrez","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ctarc.2026.101242_bib0196","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.112287","article-title":"Trimethyl chitosan coated palladium nanoparticles as a photothermal agent and its in vitro evaluation in 2D and 3D model of breast cancer cells","volume":"211","author":"Bangde","year":"2022","journal-title":"Colloids. Surf. B Biointerfaces"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0197","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41598-017-18966-8","article-title":"Multimodal tumor-homing chitosan oligosaccharide-coated biocompatible palladium nanoparticles for photo-based imaging and therapy","volume":"8","author":"Bharathiraja","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101242_bib0198","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3390\/chemistry4030063","article-title":"Magnetic nanoparticles: current advances in nanomedicine, drug delivery and MRI","volume":"4","author":"Comanescu","year":"2022","journal-title":"Chemistry"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0199","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1038\/s41598-017-05461-3","article-title":"Anti-cancerous effect of albumin coated silver nanoparticles on MDA-MB 231 human breast cancer cell line","volume":"7","author":"Azizi","year":"2017","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.ctarc.2026.101242_bib0200","doi-asserted-by":"crossref","DOI":"10.3390\/biom11121850","article-title":"CD44: A multifunctional mediator of cancer progression","volume":"11","author":"Hassn Mesrati","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ctarc.2026.101242_bib0201","doi-asserted-by":"crossref","DOI":"10.1016\/j.inoche.2022.109423","article-title":"Albumin stabilized Pt nanoparticles as radiosensitizer for sensitization of breast cancer cells under X-ray radiation therapy","volume":"140","author":"Zhang","year":"2022","journal-title":"Inorg. Chem. Commun."},{"key":"10.1016\/j.ctarc.2026.101242_bib0202","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119568","article-title":"Near-infrared light and glucose dual-responsive cascading hydroxyl radical generation for in situ gelation and effective breast cancer treatment","volume":"228","author":"Hao","year":"2020","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0203","doi-asserted-by":"crossref","first-page":"Fdd8","DOI":"10.4155\/fdd-2019-0005","article-title":"Perlecan-targeted nanoparticles for drug delivery to triple-negative breast cancer","volume":"1","author":"Khanna","year":"2019","journal-title":"Future Drug Discov."},{"issue":"14","key":"10.1016\/j.ctarc.2026.101242_bib0204","doi-asserted-by":"crossref","first-page":"7715","DOI":"10.3390\/ijms25147715","article-title":"Mesenchymal stem cell-derived exosomes as drug delivery vehicles in disease therapy","volume":"25","author":"Zhao","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ctarc.2026.101242_bib0205","article-title":"Advances in mesenchymal stem cell-derived exosomes as drug delivery vehicles","volume":"9 - 2021","author":"Rao","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101242_bib0206","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/jpm7040012","article-title":"Personalized Nanomedicine: a revolution at the nanoscale","volume":"7","author":"Fornaguera","year":"2017","journal-title":"J. Pers. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0207","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12943-023-01865-0","article-title":"Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation","volume":"22","author":"Chehelgerdi","year":"2023","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101242_bib0208","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41423-023-01034-9","article-title":"Mesenchymal stem\/stromal cells (MSCs): origin, immune regulation, and clinical applications","volume":"20","author":"Zhou","year":"2023","journal-title":"Cell Mol. Immunol."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101242_bib0209","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jcyt.2023.05.009","article-title":"Blanc KL. Lysis and phenotypic modulation of mesenchymal stromal cells upon blood contact triggers anti-inflammatory skewing of the peripheral innate immune repertoire","volume":"25","author":"Davies","year":"2023","journal-title":"Cytotherapy"},{"issue":"17","key":"10.1016\/j.ctarc.2026.101242_bib0210","doi-asserted-by":"crossref","DOI":"10.3390\/cells11172691","article-title":"Cryostorage of mesenchymal stem cells and biomedical cell-based products","volume":"11","author":"Linkova","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0211","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s13287-018-1007-x","article-title":"Short-term physiological hypoxia potentiates the therapeutic function of mesenchymal stem cells","volume":"9","author":"Antebi","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.ctarc.2026.101242_bib0212","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.3389\/fimmu.2019.01627","article-title":"The utilization of freezing steps in mesenchymal stromal cell (MSC) manufacturing: potential impact on quality and cell functionality attributes","volume":"10","author":"Oja","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101242_bib0213","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.2147\/IJN.S200036","article-title":"Mesenchymal stem cell exosomes: a two-edged sword in cancer therapy","author":"Vakhshiteh","year":"2019","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0214","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s12015-025-10985-7","article-title":"Stem cells to organoids: pioneering the future of regenerative therapies","volume":"22","author":"Kumar","year":"2026","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.ctarc.2026.101242_bib0215","unstructured":"Kumar D, Ashraf Ms, Gupta V, Tanwar R, Alshammari TM, Faiyazuddin M. Stem cell-based interventions for epilepsy: current progress and future promise. Epileptic Disord.."},{"key":"10.1016\/j.ctarc.2026.101242_bib0216","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116803","article-title":"Bibliometric and visualized analysis of the applications of exosomes based drug delivery","volume":"176","author":"Wei","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ctarc.2026.101242_bib0217","doi-asserted-by":"crossref","DOI":"10.1016\/j.vesic.2022.100010","article-title":"Greasing wheels of cell-free therapies for cardiovascular diseases: integrated devices of exosomes\/exosome-like nanovectors with bioinspired materials","volume":"1","author":"Chen","year":"2022","journal-title":"Extracell. Vesicle"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101242_bib0218","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsps.2024.102096","article-title":"Human plasma derived exosomes: impact of active and passive drug loading approaches on drug delivery","volume":"32","author":"Gul","year":"2024","journal-title":"Saudi Pharm. J."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101242_bib0219","doi-asserted-by":"crossref","first-page":"293","DOI":"10.31083\/j.fbl2710293","article-title":"Exosomes as anticancer drug delivery vehicles: prospects and challenges","volume":"27","author":"Zhang","year":"2022","journal-title":"Front. Biosci."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0220","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13287-023-03287-7","article-title":"Mesenchymal stromal\/stem cell (MSC)-derived exosomes in clinical trials","volume":"14","author":"Lotfy","year":"2023","journal-title":"Stem Cell Res. Ther."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101242_bib0221","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1039\/C9MH01197H","article-title":"Recent developments in polydopamine fluorescent nanomaterials","volume":"7","author":"Yang","year":"2020","journal-title":"Mater. Horiz."},{"key":"10.1016\/j.ctarc.2026.101242_bib0222","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114615","article-title":"The potential application of encapsulated exosomes: a new approach to increase exosomes therapeutic efficacy","volume":"162","author":"Hazrati","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101242_bib0223","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41568-022-00536-4","article-title":"Biology, vulnerabilities and clinical applications of circulating tumor cells","volume":"23","author":"Ring","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0224","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41392-024-01938-6","article-title":"Circulating tumor cells: from new biological insights to clinical practice","volume":"9","author":"Gu","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.ctarc.2026.101242_bib0225","article-title":"Recent progress of bioinspired cell membrane in cancer immunotherapy","volume":"18","author":"Zhang","year":"2024","journal-title":"Clin. Med. Insights: Oncol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101242_bib0226","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10585-024-10278-2","article-title":"Comparison of trastuzumab emtansine, trastuzumab deruxtecan, and disitamab vedotin in a multiresistant HER2-positive breast cancer lung metastasis model","volume":"41","author":"Pourjamal","year":"2024","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.ctarc.2026.101242_bib0227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2020.01.036","article-title":"Cell membrane-camouflaged nanoparticles as drug carriers for cancer therapy","volume":"105","author":"Xu","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ctarc.2026.101242_bib0228","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116951","article-title":"Recent advances in biomimetic cell membrane\u2013camouflaged nanoparticles for cancer therapy","volume":"177","author":"Alimohammadvand","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101242_bib0229","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3390\/polym10090983","article-title":"Cell membrane-camouflaged nanoparticles: a promising biomimetic strategy for cancer theragnostics","volume":"10","author":"Vijayan","year":"2018","journal-title":"Polymers"},{"issue":"10","key":"10.1016\/j.ctarc.2026.101242_bib0230","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.7150\/thno.20118","article-title":"Preparation and application of cell membrane-camouflaged nanoparticles for cancer therapy","volume":"7","author":"Zhai","year":"2017","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0231","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12951-020-00649-8","article-title":"Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy","volume":"18","author":"Gong","year":"2020","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.ctarc.2026.101242_bib0232","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3389\/fchem.2020.00377","article-title":"Platelet-membrane-camouflaged zirconia nanoparticles inhibit the invasion and metastasis of hela cells","volume":"8","author":"Shang","year":"2020","journal-title":"Front. Chem."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101242_bib0233","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2217\/nnm-2019-0388","article-title":"Cell membrane-coated nanoparticles: research advances","volume":"15","author":"Zou","year":"2020","journal-title":"Nanomedicine"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101242_bib0234","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201604774","article-title":"Antitumor platelet-mimicking magnetic nanoparticles","volume":"27","author":"Rao","year":"2017","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ctarc.2026.101242_bib0235","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jconrel.2020.01.009","article-title":"Magnetic iron oxide nanoparticles for imaging, targeting and treatment of primary and metastatic tumors of the brain","volume":"320","author":"Israel","year":"2020","journal-title":"J. Control Release"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101242_bib0236","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s13346-022-01252-0","article-title":"Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system","volume":"13","author":"Liu","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ctarc.2026.101242_bib0237","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2022.01.004","article-title":"Biomimetic platelet membrane-coated nanoparticles for targeted therapy","volume":"172","author":"Han","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0238","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s11671-022-03673-9","article-title":"Research progress of cell membrane biomimetic nanoparticles for tumor therapy","volume":"17","author":"Zhao","year":"2022","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.ctarc.2026.101242_bib0239","doi-asserted-by":"crossref","first-page":"26614","DOI":"10.1021\/acsnano.4c04814","article-title":"Platelet and erythrocyte membranes coassembled biomimetic nanoparticles for heart failure treatment","volume":"18","author":"Li","year":"2024","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101242_bib0240","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201604300","article-title":"Cancer cell membrane-coated gold nanocages with hyperthermia-triggered drug release and homotypic target inhibit growth and metastasis of breast cancer","volume":"27","author":"Sun","year":"2017","journal-title":"Adv. Funct. Mater."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101242_bib0241","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00280-018-3735-0","article-title":"Murine RAW264.7 cells as cellular drug delivery carriers for tumor therapy: a good idea?","volume":"83","author":"Zheng","year":"2019","journal-title":"Cancer Chemother Pharmacol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0242","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s13346-024-01648-0","article-title":"A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer","volume":"15","author":"Bisht","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"issue":"13","key":"10.1016\/j.ctarc.2026.101242_bib0243","doi-asserted-by":"crossref","first-page":"8906","DOI":"10.1245\/s10434-024-16266-w","article-title":"ASO author reflections: ICG fluorescent-guided surgery for sentinel lymph node biopsy used as a single tracer shown sensitivity, safety, and efficacy in early breast cancer surgery","volume":"31","author":"Pitsinis","year":"2024","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101242_bib0244","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3390\/cancers2020713","article-title":"A novel method for sentinel lymph node biopsy by indocyanine green fluorescence technique in breast cancer","volume":"2","author":"Sugie","year":"2010","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0245","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/cancers2010020","article-title":"Number of axillary lymph node metastases determined by preoperative ultrasound is related to prognosis in patients with breast cancer","volume":"2","author":"Kijima","year":"2010","journal-title":"Cancers"},{"key":"10.1016\/j.ctarc.2026.101242_bib0246","article-title":"Pseudo-Meigs\u2019 syndrome secondary to breast cancer with ovarian metastasis: a case report and literature review","volume":"13","author":"Lin","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ctarc.2026.101242_bib0247","article-title":"Case report: a rare case of breast and multiorgan metastases secondary to papillary thyroid carcinoma","volume":"14","author":"Huang","year":"2024","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101242_bib0248","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16020208","article-title":"Doxorubicin conjugated \u03b3-globulin functionalised gold nanoparticles: a pH-responsive bioinspired nanoconjugate approach for advanced chemotherapeutics","volume":"16","author":"Chauhan","year":"2024","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0249","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/10717544.2017.1422296","article-title":"Development of a novel morphological paclitaxel-loaded PLGA microspheres for effective cancer therapy: in vitro and in vivo evaluations","volume":"25","author":"Zhang","year":"2018","journal-title":"Drug Deliv."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101242_bib0250","doi-asserted-by":"crossref","DOI":"10.3390\/ph13090235","article-title":"Combination therapy with doxorubicin-loaded reduced albumin nanoparticles and focused ultrasound in mouse breast cancer xenografts","volume":"13","author":"Kim","year":"2020","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0251","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s10544-024-00698-y","article-title":"SPIONs: superparamagnetic iron oxide-based nanoparticles for the delivery of microRNAi-therapeutics in cancer","volume":"26","author":"Kara","year":"2024","journal-title":"Biomed. Microdevices"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101242_bib0252","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/jfb12040075","article-title":"Quantum dots: synthesis, antibody conjugation, and HER2-receptor targeting for breast cancer therapy","volume":"12","author":"Fatima","year":"2021","journal-title":"J. Funct. Biomater."},{"key":"10.1016\/j.ctarc.2026.101242_bib0253","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.110907","article-title":"UV irradiation of type I collagen gels changed the morphology of the interconnected brain capillary endothelial cells on them","volume":"112","author":"Mori","year":"2020","journal-title":"Mater. Sci. Eng.: C"},{"issue":"10","key":"10.1016\/j.ctarc.2026.101242_bib0254","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.3390\/biomedicines13102558","article-title":"Photothermal combination therapy for metastatic breast cancer: a new strategy and future perspectives","volume":"13","author":"Wang","year":"2025","journal-title":"Biomedicines"},{"issue":"19","key":"10.1016\/j.ctarc.2026.101242_bib0255","article-title":"Therapeutic gene silencing using targeted lipid nanoparticles in metastatic ovarian cancer","volume":"17","author":"Singh","year":"2021","journal-title":"Small"},{"issue":"23","key":"10.1016\/j.ctarc.2026.101242_bib0256","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201706759","article-title":"Cell membrane coating nanotechnology","volume":"30","author":"Fang","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ctarc.2026.101242_bib0257","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120224","article-title":"An exosome-like programmable-bioactivating paclitaxel prodrug nanoplatform for enhanced breast cancer metastasis inhibition","volume":"257","author":"Wang","year":"2020","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0258","article-title":"Thirty years from FDA approval of pegylated liposomal doxorubicin (Doxil\/Caelyx): an updated analysis and future perspective","volume":"4","author":"Gabizon","year":"2025","journal-title":"BMJ Oncol."},{"key":"10.1016\/j.ctarc.2026.101242_bib0259","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.biomaterials.2017.06.021","article-title":"Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer","volume":"140","author":"Kinoshita","year":"2017","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101242_bib0260","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.nano.2016.07.012","article-title":"Nanocarriers in cancer clinical practice: a pharmacokinetic issue","volume":"13","author":"Giodini","year":"2017","journal-title":"Nanomed.: Nanotechnol. Biol. Med."},{"key":"10.1016\/j.ctarc.2026.101242_bib0261","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113985","article-title":"Drug development of lyso-thermosensitive liposomal doxorubicin: combining hyperthermia and thermosensitive drug delivery","volume":"178","author":"Borys","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0262","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.annonc.2020.10.479","article-title":"Comparing nanoparticle polymeric micellar paclitaxel and solvent-based paclitaxel as first-line treatment of advanced non-small-cell lung cancer: an open-label, randomized, multicenter, phase III trial","volume":"32","author":"Shi","year":"2021","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101242_bib0263","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.3390\/cancers15041130","article-title":"Resistance to antibody-drug conjugates targeting HER2 in breast cancer: molecular landscape and future challenges","volume":"15","author":"Guidi","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ctarc.2026.101242_bib0264","first-page":"1","article-title":"Multimodal imaging in cancer detection: the role of SPIONs and USPIONs as contrast agents for MRI, SPECT, and PET","author":"Shaghaghi","year":"2025","journal-title":"Future Oncol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101242_bib0265","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/SLA.0000000000005633","article-title":"Sentinel lymph node mapping in breast cancer patients through fluorescent imaging using indocyanine green: the INFLUENCE trial","volume":"276","author":"Bargon","year":"2022","journal-title":"Ann. Surg."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101242_bib0266","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30071571","article-title":"Nanoparticles for photodynamic therapy of breast cancer: a review of recent studies","volume":"30","author":"Bartusik-Aebisher","year":"2025","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101242_bib0267","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.molcel.2020.05.034","article-title":"Targeting metabolism to improve the tumor microenvironment for cancer immunotherapy","volume":"78","author":"Bader","year":"2020","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101242_bib0268","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ctarc.2026.101242_bib0269","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113884","article-title":"Drug delivery carriers with therapeutic functions","volume":"176","author":"Cai","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101242_bib0270","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12282-024-01645-8","article-title":"An insight into the role of innate immune cells in breast tumor microenvironment","volume":"32","author":"Garg","year":"2025","journal-title":"Breast Cancer"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101242_bib0271","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201801002","article-title":"Nanocarriers and their loading strategies","volume":"8","author":"Wang","year":"2019","journal-title":"Adv. Healthc. Mater."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101242_bib0272","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1002\/med.21971","article-title":"(Nano) platforms in breast cancer therapy: drug\/gene delivery, advanced nanocarriers and immunotherapy","volume":"43","author":"Ashrafizadeh","year":"2023","journal-title":"Med. Res. Rev."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101242_bib0273","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.3390\/pharmaceutics15071820","article-title":"Recent advances in zein-based nanocarriers for precise cancer therapy","volume":"15","author":"Huang","year":"2023","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101242_bib0274","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.3390\/pharmaceutics15071928","article-title":"Research progress on stimulus-responsive polymer nanocarriers for cancer treatment","volume":"15","author":"Luo","year":"2023","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101242_bib0275","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.3390\/mi14091786","article-title":"Bio-inspired nanomaterials for micro\/nanodevices: a new era in biomedical applications","volume":"14","author":"Harun-Ur-Rashid","year":"2023","journal-title":"Micromachines"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246829422600153X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246829422600153X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:44:08Z","timestamp":1780919048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246829422600153X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":275,"alternative-id":["S246829422600153X"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101242","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Precision breast oncology: molecular insights and transformative clinical strategies","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101242","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101242"}}